Pieris Pharmaceuticals (PIRS)
(Delayed Data from NSDQ)
$17.24 USD
+0.25 (1.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.50 +0.26 (1.51%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For PIRS
-
Pieris Pharmaceuticals: Q2 Earnings Snapshot
-
Pieris Pharmaceuticals: Q1 Earnings Snapshot
-
Pieris Pharmaceuticals: Q3 Earnings Snapshot
-
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates
-
Pieris Pharmaceuticals: Q1 Earnings Snapshot
-
Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Lags Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates
-
Pieris Pharmaceuticals: Q3 Earnings Snapshot
-
Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Lags Revenue Estimates
-
Pieris Pharmaceuticals: Q2 Earnings Snapshot
-
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Tops Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Misses Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Misses Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Tops Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Misses Revenue Estimates
-
Analysts Estimate Pieris Pharmaceuticals (PIRS) to Report a Decline in Earnings: What to Look Out for
-
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Misses Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Tops Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Earnings Preview: Pieris Pharmaceuticals (PIRS) Q4 Earnings Expected to Decline
-
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Pieris Pharmaceuticals (PIRS) to Report a Decline in Earnings: What to Look Out for
-
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates
-
Pieris Pharmaceuticals (PIRS) Reports Break-Even Earnings for Q2